Fernando Goñi Selected Research

Fernando Goñi Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 10/2010
4	Neoplasms (Cancer) 01/2019 - 05/2008
4	Amyloid Plaque 01/2018 - 10/2010
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2018 - 12/2010
3	Scrapie 01/2015 - 12/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2020
2	Infections 01/2018 - 12/2010
2	Inflammation (Inflammations) 03/2015 - 04/2014
2	Encephalitis (Encephalitis, Rasmussen) 04/2014 - 02/2005
2	Overweight 02/2014 - 02/2011
2	Weight Gain 02/2014 - 02/2011
2	Birth Weight (Birth Weights) 01/2014 - 12/2011
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2013 - 10/2010
1	Weight Loss (Weight Reduction) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Disease Progression 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Chronic Wasting Disease 01/2015
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 01/2015
1	Amyloid angiopathy 09/2014
1	Edema (Dropsy) 04/2014
1	Premature Birth (Birth, Premature) 01/2014
1	Vitamin D Deficiency 07/2013
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2013
1	Obesity 02/2011
1	Hyperphosphatemia 12/2010
1	Hypocalcemia 12/2010
1	Pseudohypoparathyroidism 12/2010
1	Amyloidosis 10/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2010
1	Paraganglioma (Paragangliomas) 05/2008
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2008
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2008
1	Pheochromocytoma 05/2008
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 05/2008
1	Helminthiasis (Helminthiases) 04/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2015 - 10/2010
5	Amyloid (Amyloid Fibrils)IBA 01/2018 - 10/2010
3	Persistent Organic PollutantsIBA 01/2019 - 07/2013
3	PrionsIBA 01/2018 - 12/2010
3	Dichlorodiphenyl Dichloroethylene (DDE)IBA 02/2014 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2014
2	Monoclonal AntibodiesIBA 01/2018 - 01/2017
2	Salmonella VaccinesIBA 01/2015 - 12/2010
2	Hexachlorobenzene (HCB)IBA 02/2014 - 01/2014
2	Peptides (Polypeptides)IBA 12/2013 - 10/2010
2	TrihalomethanesIBA 04/2012 - 12/2011
2	VaccinesIBA 02/2005 - 04/2004
1	MetalsIBA 01/2021
1	dapagliflozinIBA 01/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2021
1	LipidsIBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	bone mealIBA 01/2015
1	Trichloroacetic AcidIBA 11/2014
1	Toll-Like Receptor 9IBA 09/2014
1	Vitamin D FDA LinkGeneric 07/2013
1	Chloral HydrateIBA 04/2012
1	AcidsIBA 04/2012
1	chloropicrinIBA 04/2012
1	3- chloro- 4- (dichloromethyl)- 5- hydroxy- 2(5H)- furanone (mutagen X)IBA 04/2012
1	Endopeptidase K (Proteinase K)IBA 03/2012
1	PrPSc ProteinsIBA 03/2012
1	Chloroform (Trichloromethane)IBA 12/2011
1	antineoplaston A10 (A 10)IBA 12/2011
1	Chlorinated HydrocarbonsIBA 02/2011
1	Endocrine DisruptorsIBA 02/2011
1	Parathyroid Hormone (Parathormone)IBA 12/2010
1	GTP-Binding Proteins (G-Protein)IBA 12/2010
1	Prion ProteinsIBA 12/2010
1	Polychlorinated Biphenyls (PCBs)IBA 09/2010
1	CatecholaminesIBA 05/2008
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2008
1	TropomyosinIBA 04/2004

Therapy/Procedure

3	Immunotherapy 01/2018 - 04/2014
3	Immunomodulation 12/2013 - 10/2010
2	Therapeutics 01/2018 - 03/2013
1	Glycemic Control 01/2021
1	Bariatric Surgery 04/2020